SCHEMBL18190930

SCHEMBL18190930

CNCc1cn(S(=O)(=O)c2cccc(OC)c2)c(-c2c(F)cccc2F)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HTR6 P50406 8/20 0.42
▸ ELAVL1 Q15717 1/20 0.41
▸ MAPT P10636 1/20 0.39
▸ MET P08581 1/20 0.39
▸ KAT6A Q92794 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.37
▸ MEP1B Q16820 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ PKLR P30613 1/20 0.37
▸ NFE2L2 Q16236 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ HTR1D P28221 1/20 0.36
▸ HTR1B P28222 1/20 0.36
▸ HTR1E P28566 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20530234 0.99 LMNA (0.42) LMNATSHRMAPK1HTR6ELAVL1
SCHEMBL18196924 0.94 HTR6 (0.41) LMNATSHRMAPK1HTR6ELAVL1
SCHEMBL18196892 0.93 HTR6 (0.41) LMNATSHRMAPK1HTR6ELAVL1
Hydrochloric Acid SCHEMBL20530241 0.93 HTR6 (0.41) LMNATSHRMAPK1HTR6ELAVL1
Hydrochloric Acid SCHEMBL20530227 0.92 HTR6 (0.40) LMNATSHRMAPK1HTR6ELAVL1
SCHEMBL18196919 0.91 HTR6 (0.40) HTR6MAPTKAT6ADRD2
SCHEMBL18196881 0.90 MAPK1 (0.44) LMNATSHRMAPK1HTR6ELAVL1
Hydrochloric Acid SCHEMBL20530215 0.90 HTR6 (0.39) HTR6MAPTKAT6ADRD2
SCHEMBL18196943 0.90 KAT6A (0.40) LMNATSHRMAPK1HTR6ELAVL1
Hydrochloric Acid SCHEMBL20530213 0.89 MAPK1 (0.43) LMNATSHRMAPK1HTR6ELAVL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197867-B1 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2018-11-14 — — EP claimed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US claimed
EP-3197867-B1 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2018-11-14 — — EP disclosed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US disclosed
EP-3197867-A2 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Daewoong Pharmaceutical Co., Ltd. (KR) 2017-08-02 — — EP disclosed
WO-2016175555-A2 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-11-03 — — WO disclosed
WO-2016175555-A2 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-11-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same GIPR, GRPR, HTR3E LMNA 4810/4885TSHR 277/4885MAPK1 878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback